Financhill
Back

Structure Therapeutics Stock Price Chart

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
36

GPCR
Structure Therapeutics

Last Price:
39.29
Seasonality Move:
-35.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight selling pressure.

Structure Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 39.15 Buy
20-day SMA: 38.81 Buy
50-day SMA: 39.59 Sell
200-day SMA: 40.27 Sell
8-day EMA: 39.42 Sell
20-day EMA: 39.31 Sell
50-day EMA: 39.42 Sell
200-day EMA: 39.72 Sell

Structure Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 49.78 Sell
Chaikin Money Flow: -61027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.61 - 41.39) Sell
Bollinger Bands (100): (36.19 - 42.83) Sell

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Structure Therapeutics Stock

Is Structure Therapeutics Stock a Buy?

GPCR Technical Analysis vs Fundamental Analysis

Sell
36
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy or a Sell?

Structure Therapeutics Stock Info

Market Cap:
2.25B
Price in USD:
39.30
Share Volume:
516.39K

Structure Therapeutics 52-Week Range

52-Week High:
72.16
52-Week Low:
26.61
Sell
36
Structure Therapeutics (GPCR) is a Sell

Structure Therapeutics Share Price Forecast

Is Structure Therapeutics Stock a Buy?

Fundamental Analysis of Structure Therapeutics

Is Structure Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.

Technical Analysis of Structure Therapeutics

Should I short Structure Therapeutics stock?

* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.